Description

Akalin et al identified risk factors for cytomegalovirus infection in recipients of renal and/or pancreatic transplant. These can help identify a patient who may benefit from higher dose or prolonged prophylaxis with ganciclovir or valganciclovir). The authors are from Mount Sinai School of Medicine in New York City.


 

Parameters:

(1) induction treatment

(2) CMV status of donor and recipient

(3) age of the patient

 

Parameter

Finding

Points

induction treatment

with thymoglobulin

1

 

without thymoglobulin

0

CMV status

donor positive, recipient negative

1

 

other

0

age of the patient

< 50 years

0

 

>= 50 years

1

 

number of risk factors =

= SUM(points for all 3 parameters)

 

Interpretation:

• minimum number of risk factors: 0

• maximum number of risk factors: 3

• The presence of either thymoglobulin induction or risky CMV status indicates a high risk patient.

• High risk patients may develop invasive CMV disease once prophylaxis is discontinued. These patient require higher doses and/or a longer period of prophylaxis (patients received either ganciclovir or valganciclovir). If infection does develop in a patient receiving prophylaxis, then resistance to the antiviral agent should be tested for.

 


To read more or access our algorithms and calculators, please log in or register.